Radiothérapie Moléculaire et Innovation Thérapeutique
- Research works
- 6 fractional, all time
- Citations
- 88 15.3 per fractional work
- Top-10% rate
- 19.6% record average 16.5%
- Open access
- 81% world 28%
Not ranked overall: Radiothérapie Moléculaire et Innovation Thérapeutique is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 11.2×. Every wedge is a field page.
Which research topics does Radiothérapie Moléculaire et Innovation Thérapeutique publish most on?
By volume in 2022–2025: Radiomics and Machine Learning in Medical Imaging, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses and vaccines and immunoinformatics approaches.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 0 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 3 Immunotherapy and Immune Responses Immunology 0 works
- 4 vaccines and immunoinformatics approaches Molecular Biology 0 works
- 5 Advanced Radiotherapy Techniques Radiation 0 works
- 6 Brain Tumor Detection and Classification Neurology 0 works
- 7 Endometrial and Cervical Cancer Treatments Obstetrics and Gynecology 0 works
- 8 Innovation Policy and R&D Economics and Econometrics 0 works
- 9 Advanced Neural Network Applications Computer Vision and Pattern Recognition 0 works
- 10 Medical Image Segmentation Techniques Computer Vision and Pattern Recognition 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Radiothérapie Moléculaire et Innovation Thérapeutique's research output changed?
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Villejuif
- Prédicteurs moléculaires et nouvelles cibles en oncologie
- Contrôle transcriptionnel et épigénétique de l’hématopoïèse maligne
- Physiopathogénèse et Traitement des Maladies du Foie
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.